
Lighthouse Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering precision medicine with novel small-molecule protease inhibitors to treat major unmet needs such as Alzheimer’s disease and other chronic degenerative and inflammatory disorders.

Investment Details
Funding Round
Seed
Milestones
Funded in 2023

About the Founder
Casey Lynch
Casey Lynch is the founder and CEO of Lighthouse Pharma, a biopharmaceutical company focused on developing innovative therapies to address unmet medical needs. Prior to founding Lighthouse Pharma, Casey built a career across life sciences and healthcare, working at the intersection of strategy, operations, and drug development. His work is driven by a commitment to advancing patient-centric solutions and translating scientific innovation into impactful treatments. Two companies she has previously founded are Cortexyme and NeuroInsights Aspira Bisystems. She as a MS in neuroscience from UCSF and a BS in neuroscience from UCLA.
Real Investors. Real Outcomes.
Start Your Investing Journey with Portfolia
Our live overview sessions are the best way to experience how Portfolia is transforming venture capital and why the experience is unmatched.
- MEET OUR PARTNERS
- LEARN HOW OUR FUNDS WORK
- SEE THE COMPANIES WE'RE BACKING.


